Sign In
Buy ATHA
$6.61
+0 (+0%)
At Close: Apr 14, 2026
Los Angeles, California--(Newsfile Corp. - July 20, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Athira Pharma, In
ATHIRA INVESTORS: August 24, 2021 Filing Deadline in Class Action – Contact Lieff Cabraser
09:00am, Tuesday, 20'th Jul 2021
SAN FRANCISCO--(BUSINESS WIRE)---- $ATHA #ATHA--ATHIRA INVESTORS: August 24, 2021 Filing Deadline in Class Action – Contact Lieff Cabraser
Athira Shareholder Alert
07:38pm, Monday, 19'th Jul 2021
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Athira To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Cor
LAWSUIT FILED: Block & Leviton LLP Has Filed a Lawsuit Against Athira Pharma, Inc. for Securities Fraud
09:44am, Monday, 19'th Jul 2021
Boston, Massachusetts--(Newsfile Corp. - July 19, 2021) - Block & Leviton LLP (www.blockleviton.com), a national securities litigation firm, announces that it has filed a class action lawsuit on behal
Los Angeles, California--(Newsfile Corp. - July 19, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Athira Pharma, In
Athira Pharma to Present ATH-1017 Phase 1 Translational Data at the Alzheimer's Association International Conference 2021 (AAIC)
07:00am, Monday, 19'th Jul 2021
BOTHELL, Wash., July 19, 2021 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health a
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Athira Pharma, Inc. - ATHA
10:20am, Sunday, 18'th Jul 2021
NEW YORK, July 18, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of. Athira Pharma, Inc. ("Athira" or the "Company") (NASDAQ: ATHA).
Athira Update
07:35pm, Saturday, 17'th Jul 2021
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Athira To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Cor
ATHIRA SHAREHOLDERS: August 24, 2021 Filing Deadline in Class Action – Contact Lieff Cabraser
09:00am, Saturday, 17'th Jul 2021
SAN FRANCISCO--(BUSINESS WIRE)---- $ATHA #ATHA--ATHIRA SHAREHOLDERS: August 24, 2021 Filing Deadline in Class Action – Contact Lieff Cabraser
Athira Class Action Reminder
07:32pm, Friday, 16'th Jul 2021
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Athira To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Cor
NEW YORK--(BUSINESS WIRE)---- $ATHA--The law firm of Kirby McInerney LLP reminds investors that securities fraud class action lawsuits have been filed in the United States District Court for the Weste
Los Angeles, California--(Newsfile Corp. - July 16, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Athira Pharma, In
New Orleans, Louisiana--(Newsfile Corp. - July 15, 2021) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have
ATHA SHAREHOLDER ALERT: Shareholders With Substantial Losses Have Opportunity to Lead the Athira Pharma, Inc. Class Action Lawsuit
05:12pm, Thursday, 15'th Jul 2021
San Diego, California--(Newsfile Corp. - July 15, 2021) - The Athira Pharma class action lawsuit charges Athira Pharma, Inc. (NASDAQ: ATHA) and its CEO with violations of the Securities Exchange Act o
San Francisco, California--(Newsfile Corp. - July 15, 2021) - Hagens Berman urges Athira Pharma, Inc. (NASDAQ: ATHA) investors with significant losses to submit your losses now. A securities class act
